[1] Zafrir B,
Salman N, Crespo-Leiro MG, et al. Body surface area as a prognostic marker in
chronic heart failure patients: results from the Heart Failure Registry of the
Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart
Fail, 2016, 18(7):859-868. DOI: 10.1002/ejhf.551.
[2] Simpson J, Castagno D, Doughty RN, et
al. Is heart rate a risk marker in patients with chronic heart failure and
concomitant atrial fibrillation? Results from the MAGGIC meta-analysis[J]. Eur
J Heart Fail, 2015, 17(11):1182-1191. DOI: 10.1002/ejhf.346.
[3] Koshy A, Pellicori P, Clark AL. The
effect of increasing inspired oxygen on exercise performance in patients with
chronic heart failure[J]. Heart, 2016, 102(8):597-601. DOI:
10.1136/heartjnl-2015-308932.
[4] Thielmann M, Pasa S, Holst T, et al.
Heart-type fatty acid binding protein and ischemia-modified albumin for
detection of myocardial infarction after coronary artery bypass graft
surgery[J]. Ann Thorac Surg, 2017, 104(1):130-137. DOI:
10.1016/j.athoracsur.2016.10.051.
[5] 李轶男,王萍,陈晖.Salusin-β与冠状动脉粥样硬化性心脏病的关系[J].中国心血管杂志,2019,24(6):583-586.
DOI:10.3969/j.issn.1007-5410.2019.06.022.
[6] Wright RS, Anderson JL, Adams CD, et al.
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for
the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial
Infarction: a report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines developed in collaboration
with the American Academy of Family Physicians, Society for Cardiovascular
Angiography and Interventions, and the Society of Thoracic Surgeons[J]. J Am
Coll Cardiol, 2011, 57(19):e215-e367. DOI: 10.1016/j.jacc.2011.02.011.
[7] Troosters T, Gosselink R, Decramer M.
Six minute walking distance in healthy elderly subjects[J]. Eur Respir J, 1999,
14(2):270-274. DOI: 10.1034/j.1399-3003.1999.14b06.x.
[8] Güneş H, Zararsız A, Gül İ, et al.
OP-080 [AJC » Chronic heart failure] Relation of levels of soluble ST2 with
clinic and prognosis in heart failure patients[J]. Am J Cardiol, 2017,
119(8):e47.
[9] Feola M, Testa M, Leto L, et al. Role of
galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in
discharged chronic heart failure patients[J]. Medicine (Baltimore), 2016,
95(26):e4014. DOI: 10.1097/MD.0000000000004014.
[10] Charach G, Grosskopf I, Galin L, et al.
Usefulness of cardiac biomarkers for prognosis of better outcomes in chronic
heart failure: retrospective 18-year follow-up study[J]. Medicine (Baltimore),
2021, 100(5):e23464. DOI: 10.1097/MD.0000000000023464.
[11] 张亭亭,李星妍,刘映辉,等.血清Copeptin与老年慢性心力衰竭患者病情严重程度关系及对预后预测作用[J].临床误诊误治,2020,33(8):68-74.
DOI:10.3969/j.issn.1002-3429.2020.08.015.
[12] Jirak P, Fejzic D, Paar V, et al.
Influences of ivabradine treatment on serum levels of cardiac biomarkers sST2,
GDF-15, suPAR and H-FABP in patients with chronic heart failure[J]. Acta
Pharmacol Sin, 2018, 39(7):1189-1196. DOI: 10.1038/aps.2017.167.
[13] Yildiz R, Ok M, Ider M, et al.
Heart-type fatty acid-binding protein (H-FABP), pentraxin-3 (PTX-3) and
thrombomodulin in bovine traumatic pericarditis[J]. Acta Vet Hung, 2019,
67(4):505-516. DOI: 10.1556/004. 2019.050.
[14] 郗汇聪,陈礴,候海文.联合检测血清脂肪酸结合蛋白和微小RNA-499在急性心肌梗死预警中的价值[J].中南医学科学杂志,2020,48(3):266-268.
DOI:10.15972/j.cnki.43-1509/r.2020.03.010.
[15] 李亚楠,张雪娥.血清心型脂肪酸结合蛋白水平与慢性心力衰竭的相关性研究[J].临床医药实践,2016,25(4):267-270.
[16] 赵子文,熊昌,黄煜,等.血清salusin-β水平与高血压患者合并冠心病及其严重程度的相关性[J].山西医科大学学报,2016,47(12):1090-1093. DOI:10.13753/j.issn.1007- 6611.2016.12.009.
[17] 高瑞敏.血清H-FABP、Hcy水平与CHF患者心室重构及预后的关系[J].心血管康复医学杂志,2019,28(4):415-419.
[18] 李轶男,王萍,陈晖.Salusin-β与冠状动脉粥样硬化性心脏病的关系[J].中国心血管杂志,2019,24(6):583-586.
DOI:10.3969/j.issn.1007-5410.2019.06.022.
[19] 丁琳,陆卫良,凌丽燕,等.心型脂肪酸结合蛋白、高敏肌钙蛋白T、氨基末端B型钠尿肽原对慢性心力衰竭的诊断价值[J].中国卫生检验杂志,2016,26(20):2962-2964.
[20] 赵振梅,马丽娜,张文霞,等.原发性高血压患者血清salusin-β水平与颈动脉病变关系[J].心脑血管病防治,2020,20(3):239-241,255. DOI:10.3969/j.issn.1009- 816x.2020.03.004.
[21] Esfahani M, Saidijam M, Najafi R, et al.
The effect of salusin-β on expression of pro- and anti-inflammatory cytokines
in human umbilical vein endothelial cells (HUVECs) [J]. ARYA Atheroscler,
2018,14(1):1-10. DOI: 10.22122/arya.v14i1.1602.
|